Melanie Cree
Concepts (379)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Polycystic Ovary Syndrome | 25 | 2024 | 141 | 14.100 |
Why?
| Insulin Resistance | 59 | 2024 | 1078 | 11.460 |
Why?
| Diabetes Mellitus, Type 2 | 31 | 2023 | 2091 | 4.570 |
Why?
| Obesity | 29 | 2024 | 2530 | 4.050 |
Why?
| Mitochondria, Muscle | 11 | 2024 | 92 | 4.040 |
Why?
| Blood Glucose | 37 | 2023 | 1826 | 3.740 |
Why?
| Glucose Intolerance | 11 | 2021 | 137 | 3.040 |
Why?
| Pediatric Obesity | 10 | 2024 | 492 | 3.030 |
Why?
| Muscle, Skeletal | 30 | 2024 | 1459 | 2.790 |
Why?
| Glucose Clamp Technique | 16 | 2023 | 181 | 2.790 |
Why?
| Metformin | 10 | 2021 | 278 | 2.500 |
Why?
| Glucose Tolerance Test | 20 | 2023 | 344 | 2.390 |
Why?
| Adolescent | 71 | 2024 | 17956 | 2.370 |
Why?
| Liver | 12 | 2023 | 1693 | 2.270 |
Why?
| Testosterone | 6 | 2023 | 336 | 2.190 |
Why?
| Insulin | 26 | 2024 | 2083 | 2.130 |
Why?
| Triglycerides | 9 | 2022 | 470 | 2.090 |
Why?
| Hyperandrogenism | 3 | 2024 | 14 | 2.070 |
Why?
| Fatty Liver | 4 | 2024 | 217 | 1.990 |
Why?
| Diabetes Mellitus, Type 1 | 17 | 2024 | 3258 | 1.790 |
Why?
| Fatty Acids, Nonesterified | 7 | 2018 | 149 | 1.730 |
Why?
| Metabolic Syndrome | 3 | 2020 | 323 | 1.690 |
Why?
| Burns | 9 | 2010 | 243 | 1.630 |
Why?
| Female | 90 | 2024 | 60081 | 1.560 |
Why?
| Body Mass Index | 11 | 2024 | 1982 | 1.500 |
Why?
| Lipid Metabolism | 6 | 2019 | 449 | 1.500 |
Why?
| Lipolysis | 4 | 2019 | 38 | 1.470 |
Why?
| Young Adult | 35 | 2024 | 10517 | 1.430 |
Why?
| Hyperinsulinism | 4 | 2019 | 103 | 1.410 |
Why?
| Fasting | 6 | 2022 | 241 | 1.360 |
Why?
| Adipose Tissue | 6 | 2022 | 553 | 1.320 |
Why?
| Child | 47 | 2022 | 18556 | 1.290 |
Why?
| Magnetic Resonance Spectroscopy | 9 | 2024 | 484 | 1.270 |
Why?
| Humans | 112 | 2024 | 115900 | 1.230 |
Why?
| Oxidative Phosphorylation | 4 | 2019 | 155 | 1.230 |
Why?
| Glycerol | 6 | 2023 | 86 | 1.220 |
Why?
| Cross-Sectional Studies | 21 | 2021 | 4449 | 1.210 |
Why?
| Hypoglycemic Agents | 9 | 2019 | 1008 | 1.200 |
Why?
| Glucose | 10 | 2023 | 904 | 1.100 |
Why?
| Exercise | 12 | 2024 | 1611 | 1.050 |
Why?
| Insulin-Secreting Cells | 6 | 2020 | 318 | 1.050 |
Why?
| Body Composition | 6 | 2024 | 581 | 1.030 |
Why?
| Case-Control Studies | 15 | 2024 | 3056 | 1.020 |
Why?
| Cardiovascular Diseases | 6 | 2019 | 1724 | 0.970 |
Why?
| Gastrointestinal Microbiome | 2 | 2021 | 502 | 0.930 |
Why?
| Sleep Initiation and Maintenance Disorders | 2 | 2020 | 116 | 0.920 |
Why?
| Male | 65 | 2024 | 56126 | 0.900 |
Why?
| Androgens | 2 | 2022 | 165 | 0.890 |
Why?
| Prediabetic State | 4 | 2021 | 225 | 0.880 |
Why?
| Transition to Adult Care | 1 | 2024 | 60 | 0.870 |
Why?
| Circadian Rhythm | 4 | 2019 | 372 | 0.870 |
Why?
| Hyperglycemia | 4 | 2021 | 295 | 0.850 |
Why?
| Adult | 42 | 2024 | 30817 | 0.840 |
Why?
| Non-alcoholic Fatty Liver Disease | 3 | 2021 | 246 | 0.810 |
Why?
| Adenosine Diphosphate | 2 | 2021 | 81 | 0.760 |
Why?
| Obesity, Morbid | 1 | 2024 | 198 | 0.750 |
Why?
| Klinefelter Syndrome | 1 | 2021 | 49 | 0.740 |
Why?
| Desogestrel | 1 | 2020 | 40 | 0.720 |
Why?
| Adolescent Medicine | 1 | 2020 | 35 | 0.710 |
Why?
| Lipogenesis | 2 | 2019 | 57 | 0.710 |
Why?
| Isotopes | 1 | 2019 | 27 | 0.690 |
Why?
| Energy Metabolism | 3 | 2024 | 712 | 0.690 |
Why?
| Endocrinology | 1 | 2020 | 69 | 0.680 |
Why?
| Inservice Training | 1 | 2020 | 107 | 0.680 |
Why?
| Sleep Disorders, Circadian Rhythm | 1 | 2019 | 39 | 0.660 |
Why?
| Absorptiometry, Photon | 6 | 2024 | 221 | 0.660 |
Why?
| Gluconeogenesis | 1 | 2019 | 60 | 0.660 |
Why?
| Obesity, Abdominal | 1 | 2018 | 38 | 0.640 |
Why?
| Mentors | 1 | 2020 | 162 | 0.630 |
Why?
| Mentoring | 1 | 2020 | 103 | 0.620 |
Why?
| Interprofessional Relations | 1 | 2020 | 258 | 0.610 |
Why?
| Adiposity | 4 | 2018 | 467 | 0.600 |
Why?
| Gynecology | 1 | 2020 | 184 | 0.590 |
Why?
| Fatty Acids | 2 | 2019 | 385 | 0.590 |
Why?
| Fenofibrate | 2 | 2007 | 24 | 0.580 |
Why?
| Depressive Disorder | 1 | 2020 | 337 | 0.570 |
Why?
| Amino Acids | 3 | 2019 | 455 | 0.570 |
Why?
| Lipoproteins, HDL | 1 | 2017 | 76 | 0.570 |
Why?
| Overweight | 5 | 2021 | 468 | 0.560 |
Why?
| C-Peptide | 5 | 2019 | 137 | 0.560 |
Why?
| Biodiversity | 1 | 2020 | 365 | 0.560 |
Why?
| Hypolipidemic Agents | 2 | 2007 | 87 | 0.550 |
Why?
| Oxygen Consumption | 8 | 2021 | 572 | 0.520 |
Why?
| Prognosis | 5 | 2020 | 3342 | 0.490 |
Why?
| Muscle Proteins | 7 | 2017 | 214 | 0.490 |
Why?
| Aging | 3 | 2019 | 1641 | 0.490 |
Why?
| Diabetes Mellitus | 2 | 2020 | 906 | 0.480 |
Why?
| Mitochondria | 4 | 2021 | 753 | 0.480 |
Why?
| Lipoproteins | 1 | 2015 | 162 | 0.470 |
Why?
| B-Lymphocytes | 1 | 2019 | 770 | 0.470 |
Why?
| Bacteria | 1 | 2020 | 731 | 0.460 |
Why?
| Sleep | 3 | 2019 | 626 | 0.460 |
Why?
| Decision Making | 1 | 2020 | 792 | 0.460 |
Why?
| Severity of Illness Index | 3 | 2020 | 2598 | 0.460 |
Why?
| Oxygen | 1 | 2018 | 839 | 0.450 |
Why?
| PPAR alpha | 3 | 2007 | 52 | 0.440 |
Why?
| Follow-Up Studies | 6 | 2020 | 4446 | 0.440 |
Why?
| Risk Factors | 11 | 2021 | 8714 | 0.420 |
Why?
| Bed Rest | 2 | 2009 | 15 | 0.420 |
Why?
| Calorimetry, Indirect | 2 | 2024 | 64 | 0.400 |
Why?
| Insulin Glargine | 3 | 2019 | 73 | 0.400 |
Why?
| Cohort Studies | 7 | 2021 | 4961 | 0.390 |
Why?
| Cystic Fibrosis | 1 | 2020 | 961 | 0.380 |
Why?
| Hirsutism | 2 | 2021 | 10 | 0.360 |
Why?
| Cushing Syndrome | 1 | 2009 | 10 | 0.350 |
Why?
| Gastroplasty | 2 | 2021 | 26 | 0.350 |
Why?
| Prospective Studies | 7 | 2020 | 6267 | 0.350 |
Why?
| Algorithms | 2 | 2021 | 1493 | 0.350 |
Why?
| Diabetic Nephropathies | 3 | 2020 | 234 | 0.340 |
Why?
| Magnetic Resonance Imaging | 5 | 2021 | 3086 | 0.340 |
Why?
| Estradiol | 3 | 2022 | 453 | 0.340 |
Why?
| Middle Aged | 14 | 2024 | 27083 | 0.330 |
Why?
| Puberty | 2 | 2022 | 137 | 0.320 |
Why?
| Sleep Apnea, Obstructive | 1 | 2021 | 194 | 0.300 |
Why?
| Exercise Tolerance | 4 | 2017 | 223 | 0.290 |
Why?
| Protein Kinase C | 1 | 2008 | 274 | 0.280 |
Why?
| Retrospective Studies | 7 | 2021 | 12616 | 0.270 |
Why?
| Autoimmunity | 1 | 2012 | 823 | 0.270 |
Why?
| Diabetic Cardiomyopathies | 2 | 2016 | 35 | 0.270 |
Why?
| Carnitine | 3 | 2019 | 61 | 0.250 |
Why?
| Adiponectin | 2 | 2016 | 213 | 0.240 |
Why?
| Aged | 11 | 2020 | 19299 | 0.240 |
Why?
| Lipoproteins, VLDL | 1 | 2024 | 21 | 0.240 |
Why?
| Adenosine Triphosphate | 2 | 2021 | 430 | 0.230 |
Why?
| Basal Metabolism | 1 | 2024 | 44 | 0.230 |
Why?
| Age Factors | 3 | 2020 | 2915 | 0.230 |
Why?
| Leg | 5 | 2021 | 227 | 0.230 |
Why?
| Lipids | 4 | 2017 | 589 | 0.230 |
Why?
| Muscle Contraction | 3 | 2014 | 398 | 0.230 |
Why?
| Endocrine System Diseases | 1 | 2023 | 32 | 0.220 |
Why?
| Reproducibility of Results | 7 | 2023 | 2814 | 0.220 |
Why?
| Colorado | 5 | 2020 | 4122 | 0.220 |
Why?
| Muscle Strength | 2 | 2017 | 278 | 0.220 |
Why?
| Vascular Stiffness | 2 | 2019 | 411 | 0.220 |
Why?
| Biomarkers | 6 | 2019 | 3473 | 0.220 |
Why?
| Sex Factors | 3 | 2017 | 1743 | 0.210 |
Why?
| Carbon Isotopes | 4 | 2019 | 112 | 0.210 |
Why?
| Double-Blind Method | 3 | 2019 | 1665 | 0.210 |
Why?
| Actigraphy | 2 | 2019 | 74 | 0.200 |
Why?
| Cardiorespiratory Fitness | 2 | 2019 | 34 | 0.200 |
Why?
| Sleep Wake Disorders | 2 | 2019 | 234 | 0.200 |
Why?
| Phosphocreatine | 1 | 2021 | 36 | 0.200 |
Why?
| Melatonin | 2 | 2019 | 106 | 0.200 |
Why?
| Glutathione | 1 | 2023 | 303 | 0.200 |
Why?
| Child, Preschool | 8 | 2022 | 9176 | 0.190 |
Why?
| Alopecia | 1 | 2021 | 28 | 0.190 |
Why?
| Bacteroidetes | 1 | 2021 | 20 | 0.190 |
Why?
| Firmicutes | 1 | 2021 | 17 | 0.190 |
Why?
| Body Weight | 2 | 2019 | 872 | 0.190 |
Why?
| Protein Biosynthesis | 2 | 2017 | 388 | 0.190 |
Why?
| Time Factors | 5 | 2019 | 6186 | 0.190 |
Why?
| Contraceptive Devices, Female | 1 | 2020 | 9 | 0.190 |
Why?
| Ovarian Reserve | 1 | 2020 | 13 | 0.180 |
Why?
| Sex Chromosome Disorders of Sex Development | 1 | 2020 | 9 | 0.180 |
Why?
| Drug Implants | 1 | 2020 | 71 | 0.180 |
Why?
| Carotid Intima-Media Thickness | 2 | 2018 | 65 | 0.180 |
Why?
| Primary Ovarian Insufficiency | 1 | 2020 | 30 | 0.180 |
Why?
| United States | 3 | 2021 | 12340 | 0.180 |
Why?
| Physicians, Women | 1 | 2020 | 55 | 0.170 |
Why?
| Glucose Metabolism Disorders | 1 | 2019 | 10 | 0.170 |
Why?
| Arginine | 2 | 2019 | 241 | 0.170 |
Why?
| Aorta | 2 | 2019 | 354 | 0.170 |
Why?
| Prednisolone | 1 | 2019 | 77 | 0.170 |
Why?
| Liraglutide | 1 | 2019 | 27 | 0.170 |
Why?
| Device Removal | 1 | 2020 | 128 | 0.170 |
Why?
| Sitagliptin Phosphate | 1 | 2019 | 30 | 0.170 |
Why?
| Amino Acids, Essential | 2 | 2009 | 12 | 0.170 |
Why?
| Uromodulin | 1 | 2019 | 21 | 0.170 |
Why?
| Virilism | 1 | 2019 | 5 | 0.170 |
Why?
| Predictive Value of Tests | 1 | 2024 | 1817 | 0.170 |
Why?
| Waist Circumference | 1 | 2019 | 123 | 0.170 |
Why?
| Menstruation Disturbances | 1 | 2019 | 12 | 0.160 |
Why?
| Adrenocorticotropic Hormone | 1 | 2019 | 148 | 0.160 |
Why?
| Sex Hormone-Binding Globulin | 1 | 2019 | 47 | 0.160 |
Why?
| Contraceptives, Oral | 1 | 2019 | 25 | 0.160 |
Why?
| Withholding Treatment | 1 | 2019 | 69 | 0.160 |
Why?
| Diastole | 1 | 2019 | 135 | 0.160 |
Why?
| Dipeptidyl-Peptidase IV Inhibitors | 1 | 2019 | 43 | 0.160 |
Why?
| Peer Group | 1 | 2020 | 208 | 0.160 |
Why?
| Spironolactone | 1 | 2019 | 33 | 0.160 |
Why?
| Respiratory Function Tests | 1 | 2020 | 541 | 0.160 |
Why?
| RNA, Ribosomal, 16S | 1 | 2021 | 492 | 0.160 |
Why?
| Feces | 1 | 2021 | 374 | 0.160 |
Why?
| Erythrocytes | 1 | 2023 | 590 | 0.160 |
Why?
| Deuterium | 3 | 2015 | 78 | 0.160 |
Why?
| Minority Groups | 1 | 2020 | 232 | 0.160 |
Why?
| Wakefulness | 1 | 2019 | 128 | 0.160 |
Why?
| Career Choice | 1 | 2020 | 182 | 0.160 |
Why?
| Cell Respiration | 1 | 2018 | 74 | 0.150 |
Why?
| Intra-Abdominal Fat | 1 | 2018 | 84 | 0.150 |
Why?
| Cardiotonic Agents | 1 | 2018 | 119 | 0.150 |
Why?
| Psychiatric Status Rating Scales | 1 | 2020 | 485 | 0.150 |
Why?
| Saliva | 1 | 2019 | 189 | 0.150 |
Why?
| Universities | 1 | 2020 | 341 | 0.150 |
Why?
| Spasms, Infantile | 1 | 2019 | 105 | 0.150 |
Why?
| Kidney | 4 | 2021 | 1208 | 0.150 |
Why?
| Incidence | 2 | 2021 | 2333 | 0.150 |
Why?
| Social Media | 1 | 2020 | 135 | 0.150 |
Why?
| Phosphorus Isotopes | 1 | 2017 | 8 | 0.150 |
Why?
| Occupational Exposure | 1 | 2020 | 263 | 0.150 |
Why?
| Affect | 1 | 2019 | 244 | 0.140 |
Why?
| Child Behavior | 1 | 2019 | 218 | 0.140 |
Why?
| Hindlimb | 1 | 2017 | 125 | 0.140 |
Why?
| Blood Vessels | 1 | 2018 | 181 | 0.140 |
Why?
| Prevalence | 2 | 2021 | 2271 | 0.140 |
Why?
| Parenting | 1 | 2020 | 257 | 0.140 |
Why?
| Human Development | 1 | 2016 | 15 | 0.140 |
Why?
| Social Support | 1 | 2020 | 541 | 0.140 |
Why?
| Regional Blood Flow | 2 | 2016 | 414 | 0.140 |
Why?
| Hospitals, Pediatric | 2 | 2017 | 478 | 0.140 |
Why?
| Bone Density | 1 | 2020 | 432 | 0.140 |
Why?
| Societies, Medical | 1 | 2020 | 690 | 0.140 |
Why?
| Placental Insufficiency | 1 | 2017 | 103 | 0.140 |
Why?
| Estrogens | 1 | 2019 | 316 | 0.130 |
Why?
| Metabolome | 1 | 2019 | 284 | 0.130 |
Why?
| Milk Proteins | 2 | 2006 | 36 | 0.130 |
Why?
| Leptin | 1 | 2017 | 211 | 0.130 |
Why?
| Schools | 1 | 2018 | 401 | 0.130 |
Why?
| Drug Therapy, Combination | 1 | 2018 | 961 | 0.130 |
Why?
| Glucocorticoids | 1 | 2019 | 551 | 0.130 |
Why?
| Life Style | 2 | 2018 | 428 | 0.130 |
Why?
| Pneumonia, Viral | 1 | 2020 | 343 | 0.130 |
Why?
| Coronavirus Infections | 1 | 2020 | 335 | 0.120 |
Why?
| Sex Characteristics | 2 | 2017 | 644 | 0.120 |
Why?
| Pulse Wave Analysis | 3 | 2021 | 207 | 0.120 |
Why?
| Exercise Therapy | 1 | 2018 | 353 | 0.120 |
Why?
| Glomerular Filtration Rate | 4 | 2020 | 605 | 0.120 |
Why?
| Phosphorus | 1 | 2014 | 81 | 0.120 |
Why?
| Metabolomics | 1 | 2019 | 535 | 0.120 |
Why?
| Biopsy | 2 | 2008 | 1056 | 0.120 |
Why?
| Surveys and Questionnaires | 2 | 2020 | 4671 | 0.120 |
Why?
| Inflammation Mediators | 1 | 2017 | 481 | 0.110 |
Why?
| Blood Pressure | 2 | 2017 | 1536 | 0.110 |
Why?
| Echocardiography | 1 | 2016 | 566 | 0.110 |
Why?
| Ventricular Function, Left | 1 | 2016 | 468 | 0.110 |
Why?
| Fetal Growth Retardation | 1 | 2017 | 467 | 0.110 |
Why?
| Area Under Curve | 3 | 2008 | 277 | 0.100 |
Why?
| Models, Biological | 1 | 2019 | 1647 | 0.100 |
Why?
| Physicians | 1 | 2020 | 774 | 0.100 |
Why?
| Pandemics | 1 | 2020 | 1333 | 0.100 |
Why?
| Emotions | 1 | 2017 | 486 | 0.100 |
Why?
| Pyruvic Acid | 2 | 2010 | 41 | 0.100 |
Why?
| Models, Theoretical | 1 | 2015 | 527 | 0.100 |
Why?
| Hypoglycemia | 1 | 2016 | 387 | 0.100 |
Why?
| Disease Progression | 2 | 2022 | 2424 | 0.100 |
Why?
| Hypertension | 1 | 2019 | 1063 | 0.100 |
Why?
| Linear Models | 2 | 2014 | 778 | 0.100 |
Why?
| Treatment Outcome | 6 | 2019 | 9165 | 0.100 |
Why?
| Creatinine | 3 | 2020 | 431 | 0.090 |
Why?
| Internship and Residency | 1 | 2020 | 949 | 0.090 |
Why?
| Jet Lag Syndrome | 1 | 2019 | 7 | 0.080 |
Why?
| Acyl Coenzyme A | 2 | 2006 | 29 | 0.080 |
Why?
| Diabetes, Gestational | 1 | 2012 | 274 | 0.080 |
Why?
| Hypertriglyceridemia | 1 | 2008 | 34 | 0.080 |
Why?
| Palmitates | 1 | 2008 | 15 | 0.080 |
Why?
| Protein Kinase C beta | 1 | 2008 | 24 | 0.080 |
Why?
| Quality Improvement | 1 | 2016 | 956 | 0.080 |
Why?
| Spectrometry, Mass, Electrospray Ionization | 2 | 2005 | 167 | 0.080 |
Why?
| Risk Assessment | 1 | 2017 | 3004 | 0.070 |
Why?
| Hospitalization | 1 | 2016 | 1761 | 0.070 |
Why?
| Muscle Cells | 1 | 2007 | 41 | 0.070 |
Why?
| Chromatography, High Pressure Liquid | 2 | 2005 | 477 | 0.070 |
Why?
| Albuminuria | 2 | 2020 | 164 | 0.070 |
Why?
| Acetates | 1 | 2007 | 95 | 0.070 |
Why?
| Trauma Severity Indices | 1 | 2007 | 111 | 0.070 |
Why?
| Animals | 8 | 2017 | 32121 | 0.070 |
Why?
| Islets of Langerhans | 1 | 2012 | 729 | 0.070 |
Why?
| Phenylalanine | 4 | 2009 | 58 | 0.070 |
Why?
| Critical Care | 1 | 2010 | 476 | 0.070 |
Why?
| Muscular Atrophy | 1 | 2006 | 76 | 0.070 |
Why?
| Carbon Dioxide | 1 | 2007 | 210 | 0.070 |
Why?
| Milk | 1 | 2006 | 124 | 0.060 |
Why?
| Self Report | 1 | 2019 | 701 | 0.060 |
Why?
| Oxidation-Reduction | 1 | 2008 | 933 | 0.060 |
Why?
| Caseins | 1 | 2004 | 21 | 0.060 |
Why?
| Cystatin C | 2 | 2014 | 61 | 0.060 |
Why?
| Albumins | 1 | 2005 | 91 | 0.060 |
Why?
| Fibrinogen | 1 | 2005 | 160 | 0.060 |
Why?
| Mitochondrial Diseases | 1 | 2024 | 77 | 0.060 |
Why?
| Physical Exertion | 1 | 2005 | 208 | 0.060 |
Why?
| Placebos | 2 | 2019 | 198 | 0.060 |
Why?
| Stress, Physiological | 1 | 2006 | 397 | 0.060 |
Why?
| Glycolysis | 1 | 2024 | 222 | 0.050 |
Why?
| Exercise Test | 3 | 2016 | 541 | 0.050 |
Why?
| Dietary Carbohydrates | 1 | 2003 | 136 | 0.050 |
Why?
| Critical Illness | 1 | 2007 | 646 | 0.050 |
Why?
| Culture Media, Conditioned | 1 | 2022 | 105 | 0.050 |
Why?
| Regression Analysis | 1 | 2004 | 961 | 0.050 |
Why?
| Pregnancy | 3 | 2020 | 5555 | 0.050 |
Why?
| Gonadotropins | 1 | 2020 | 37 | 0.050 |
Why?
| Hydroxyestrones | 1 | 2000 | 2 | 0.050 |
Why?
| Isoflavones | 1 | 2000 | 16 | 0.040 |
Why?
| Chromosomes, Human, X | 1 | 2020 | 60 | 0.040 |
Why?
| Sex Chromosome Aberrations | 1 | 2020 | 51 | 0.040 |
Why?
| Anti-Mullerian Hormone | 1 | 2020 | 50 | 0.040 |
Why?
| Parental Leave | 1 | 2020 | 17 | 0.040 |
Why?
| Trisomy | 1 | 2020 | 68 | 0.040 |
Why?
| Salaries and Fringe Benefits | 1 | 2020 | 53 | 0.040 |
Why?
| Causality | 1 | 2019 | 106 | 0.040 |
Why?
| Administration, Oral | 3 | 2006 | 731 | 0.040 |
Why?
| Practice Guidelines as Topic | 2 | 2017 | 1403 | 0.040 |
Why?
| Sulfonylurea Compounds | 1 | 2019 | 44 | 0.040 |
Why?
| Hormones | 1 | 2019 | 132 | 0.040 |
Why?
| Rats, Zucker | 2 | 2010 | 26 | 0.040 |
Why?
| Biological Transport | 2 | 2010 | 373 | 0.040 |
Why?
| Diabetic Angiopathies | 1 | 2019 | 243 | 0.040 |
Why?
| Magnetic Resonance Angiography | 1 | 2018 | 209 | 0.040 |
Why?
| Longitudinal Studies | 1 | 2023 | 2437 | 0.030 |
Why?
| Sensitivity and Specificity | 1 | 2021 | 1728 | 0.030 |
Why?
| Infant, Newborn | 2 | 2020 | 5089 | 0.030 |
Why?
| Whey Proteins | 2 | 2006 | 5 | 0.030 |
Why?
| Physicians, Primary Care | 1 | 2018 | 222 | 0.030 |
Why?
| Echocardiography, Doppler | 1 | 2016 | 90 | 0.030 |
Why?
| Tertiary Care Centers | 1 | 2016 | 127 | 0.030 |
Why?
| Sheep | 1 | 2017 | 766 | 0.030 |
Why?
| Infant | 2 | 2019 | 8002 | 0.030 |
Why?
| Comorbidity | 1 | 2019 | 1476 | 0.030 |
Why?
| Oxidative Stress | 1 | 2021 | 1096 | 0.030 |
Why?
| Diagnosis, Differential | 1 | 2018 | 1358 | 0.030 |
Why?
| Rabbits | 2 | 2005 | 754 | 0.030 |
Why?
| Stress, Mechanical | 1 | 2016 | 440 | 0.030 |
Why?
| Weight Loss | 1 | 2018 | 632 | 0.030 |
Why?
| Mothers | 1 | 2020 | 667 | 0.030 |
Why?
| Cyclic AMP Response Element-Binding Protein | 1 | 2014 | 128 | 0.030 |
Why?
| Nitric Oxide Synthase Type III | 1 | 2014 | 185 | 0.030 |
Why?
| Biomechanical Phenomena | 1 | 2016 | 678 | 0.030 |
Why?
| Cholesterol, LDL | 1 | 2014 | 309 | 0.030 |
Why?
| Diet | 1 | 2000 | 1075 | 0.030 |
Why?
| Glucagon | 1 | 2012 | 93 | 0.030 |
Why?
| Parents | 1 | 2020 | 1210 | 0.020 |
Why?
| Multivariate Analysis | 1 | 2014 | 1444 | 0.020 |
Why?
| Malonyl Coenzyme A | 1 | 2010 | 5 | 0.020 |
Why?
| Acetyl-CoA Carboxylase | 1 | 2010 | 33 | 0.020 |
Why?
| Adaptation, Physiological | 1 | 2014 | 476 | 0.020 |
Why?
| Glycogen | 1 | 2010 | 52 | 0.020 |
Why?
| Rats | 2 | 2010 | 5035 | 0.020 |
Why?
| Sciatic Nerve | 1 | 2010 | 56 | 0.020 |
Why?
| Infusions, Intravenous | 1 | 2010 | 374 | 0.020 |
Why?
| Cholesterol, VLDL | 1 | 2008 | 4 | 0.020 |
Why?
| Clinical Protocols | 1 | 2010 | 233 | 0.020 |
Why?
| Primary Health Care | 1 | 2018 | 1517 | 0.020 |
Why?
| Lactic Acid | 1 | 2010 | 276 | 0.020 |
Why?
| Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 794 | 0.020 |
Why?
| Drug Administration Schedule | 1 | 2010 | 724 | 0.020 |
Why?
| Radioactive Tracers | 1 | 2007 | 5 | 0.020 |
Why?
| Citric Acid Cycle | 1 | 2007 | 42 | 0.020 |
Why?
| Sodium Bicarbonate | 1 | 2007 | 40 | 0.020 |
Why?
| Breath Tests | 1 | 2007 | 85 | 0.020 |
Why?
| Cholesterol | 1 | 2008 | 367 | 0.020 |
Why?
| Multienzyme Complexes | 1 | 2006 | 64 | 0.020 |
Why?
| Diglycerides | 1 | 2006 | 55 | 0.020 |
Why?
| Palmitoylcarnitine | 1 | 2005 | 1 | 0.020 |
Why?
| Carbohydrate Sequence | 1 | 2005 | 23 | 0.020 |
Why?
| Methods | 1 | 2005 | 59 | 0.020 |
Why?
| Palmitic Acid | 1 | 2005 | 36 | 0.020 |
Why?
| AMP-Activated Protein Kinases | 1 | 2006 | 175 | 0.020 |
Why?
| Reference Standards | 1 | 2005 | 161 | 0.020 |
Why?
| Mitogen-Activated Protein Kinases | 1 | 2006 | 277 | 0.020 |
Why?
| Dietary Supplements | 1 | 2008 | 460 | 0.020 |
Why?
| Metabolic Clearance Rate | 1 | 2005 | 108 | 0.020 |
Why?
| Weight Lifting | 1 | 2004 | 29 | 0.020 |
Why?
| Hydrocortisone | 1 | 2006 | 272 | 0.020 |
Why?
| Phenotype | 1 | 2012 | 2858 | 0.010 |
Why?
| Patient Discharge | 1 | 2010 | 770 | 0.010 |
Why?
| Leucine | 1 | 2004 | 111 | 0.010 |
Why?
| Fluorocarbons | 1 | 2005 | 96 | 0.010 |
Why?
| Chromatography, Liquid | 1 | 2005 | 346 | 0.010 |
Why?
| Heart Rate | 1 | 2007 | 698 | 0.010 |
Why?
| Analysis of Variance | 1 | 2006 | 1226 | 0.010 |
Why?
| Blood Proteins | 1 | 2005 | 238 | 0.010 |
Why?
| Phosphorylation | 1 | 2006 | 1560 | 0.010 |
Why?
| Motor Activity | 1 | 2006 | 636 | 0.010 |
Why?
| Amino Acid Sequence | 1 | 2005 | 2000 | 0.010 |
Why?
| Molecular Sequence Data | 1 | 2005 | 2793 | 0.010 |
Why?
| Neoplasms, Hormone-Dependent | 1 | 2000 | 38 | 0.010 |
Why?
| Premenopause | 1 | 2000 | 104 | 0.010 |
Why?
| Gene Expression Regulation | 1 | 2005 | 2362 | 0.010 |
Why?
| Signal Transduction | 1 | 2006 | 4525 | 0.010 |
Why?
| Breast Neoplasms | 1 | 2000 | 1870 | 0.000 |
Why?
|
|
Cree's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|